This finding was further confirmed in Alzheimer’s disease model mice, where co-administration of insulin with L-penetratin resulted in slower memory loss progression than co-administration of insulin with D-penetratin or with the administration of insulin alone [178]. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.